Target intelligence / Profile preview

ANAPC1 pseudogene 2 (ANAPC1P2)

Target
ANAPC1P2
Molecular classification
Other (pseudogene)
01

Overview

ANAPC1 pseudogene 2 (ANAPC1P2) is classified as a pseudogene, meaning it is a non-coding DNA sequence similar to the anaphase promoting complex subunit 1 (ANAPC1) gene but does not code for a functional protein product. It is listed in gene databases (e.g., GeneCards, BioGPS) as a pseudogene, located on chromosome 2 (NCBI Gene ID: 285074), with no evidence for protein-coding potential or direct biological function[4][5]. Pseudogenes such as ANAPC1P2 are not therapeutic targets, do not act as receptors, enzymes, or other druggable molecules, and have no established relevance in human disease or pharmacology. *Note: This entry is not a valid therapeutic or pharmacological target and serves only as a genomic annotation. If information on the true functional gene (ANAPC1) is required, refer instead to "anaphase promoting complex subunit 1 (ANAPC1)," which is a functional cell cycle regulator protein[1][2][3].*

Other names
ANAPC1P2anaphase promoting complex subunit 1 pseudogeneANAPC1 pseudogene 2
02

Mechanism of action

None

03

Biological functions

None known (pseudogene; typically does not encode a functional product)
04

Disease associations

None established (pseudogene; not known to be causative or actionable in disease)

Beyond the preview

Go deeper on ANAPC1 pseudogene 2 (ANAPC1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANAPC1 pseudogene 2 (ANAPC1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call